Before the launch of GLP-1s, Insulin used to contribute 75-80%
Healthline recently spoke with Federica Amati, PhD, a postdoctoral medical scientist and head nutritionist at ZOE, a science and nutrition company
For GLP-1 medications, this means patients can access both compounded and brand-name options including semaglutide, tirzepatide, Wegovy, and Zepbound, depending on what the individual provider offers
Second Natures published research shows that members taking semaglutide alongside dietitian-led behaviour change support achieved an average weight loss of 19.1% at 12 months, with 77.7% achieving 10% or more weight loss
Wegovy (semaglutide) Wegovy is the same medication as Ozempic and was FDA-approved for chronic weight management in 2021
It slows gastric emptying, increases feelings of fullness, and reduces hunger signals in the brain